Ninety-nine unselected patients were given a standardized general anaesthetic with fentanyl 1.5 rag' kg -~ every 30 minutes and were randomly divided into three equal Groups: Group 1 patients received naloxone 0. I mg, Group It naloxone 0.2 mg, and Group III naloxone 0.4 rag, at the end of operation and after the reversal of neuromuscular blockade. After administration of naloxone systolic blood pressure increased by 4, 8 and 7 per cent and mean arterial blood pressure increased by 3, 8 and 8 per cent in Groups I, II and III respectively; heart rate increased by 4, I 1 and 8 per cent and rate-pressure product increased by 7, 18 and 15 per cent in Groups 1, II and Ill respectively. Tidal volume increased by 97, 101 and 95 per cent and minute volume increased by 122, 164 and 143 percent in Groups I, II and III respectively after naloxone. Forty-nine percent of patients had a tidal volume of less than 5 ml. kg -~ ora minute volume of less than 50 ml. kg -~ before adminislration of naloxone; after naloxone three patients in Group I (naloxone 0. I rag) had a tidal volume of less than 5 ml. kg-~ and no patient had a respiratory minute volume of less than 50 ml. kg-L It is concluded that under the conditions of this study naloxone 0. I mg is adequate to reverse the respiratory depressant effect of fentanyl in the majority of cases.
IN RECENT YEARS there has been a resurgence of interest in narcotic-supplemented general anaesthesia. At the present time fentanyl enjoys much popularity due to its advantageous pharmacological properties, particularly its potency, lack of cardiovascular side effects and rapid onset of action.~ Further, post-anaesthetic respiratory inadequacy may easily be reversed with naloxonc. :-5
The present study was designed to determine the effect of varying doses of naloxone on the circulation and respiration after low-dose fentanyl-nitrous oxide: oxygen anaesthesia, with intermittent positive pressure ventilation, for a wide range of operative procedures.
PATIENTS AND METHODS
Ninety-nine unseleeted patients took part in this study, undergoing a wide variety of operative procedures and all had their weight, height, age, habitus and A.S.A. physical status recorded preoperatively.
The study was approved by the Ethics Committee and the Research and Special Services Committee of the University of Alberta Hospital, Edmonton, and all patients were visited by the J.G. Purdell-Lewis, M.B., B.S., F.R.C.P.(C), Department of Anaesthesia, University of Alberta Hospital. Edmonton, Alberta, T6G 2B7. author preoperatively and gave verbal consent before being included in the study.
Premedication was with oral diazepam, given two hours preoperatively, at 7.5 mg for patients under 50 kg weight and 10.0 mg for those over 50 kg.
Anaesthesia was induced with fentanyl 1.5 lag' kg -~ . followed by thiopentone 3-5 mg. kg -~ intravenously and an intravenous neuromuscular blocking agent to facilitate laryngoscopy and tracheal intubation. Anaesthesia was maintained with nitrous oxide: oxygen and intravenous fentanyl 1.5 lag' kg -~ every half-hour. Most patients received pancuronium bromide and the remainder d-tubocurare or succinylcholine chloride. Ventilation was by intermittent positive pressure through a Bain circuit or circle system without carbon dioxide absorption. Tidal volume was set at 10 ml. kg -t and rate at 10 to 12 breaths per minute.
Monitoring in the operating room included the electrocardiogram displayed on an oscilloscope (Tektronix 412 Monitor), blood pressure obtained by auscultation, inspired oxygen concentration (Ohio Model 200 Polarographic Oxygen Monitor) and arterial or arterialized-venous blood gas determinations (IL Model 513 pH/Blood Gas Analyzer). Tidal volume and minute volume were measured (Medishield Wright Respiration Monitor) and the degree of Canad. Anaesth. Soc. J., vol. 27, no. 4, July 1980 323 neuromuscular blockade was monitored by peripheral nerve stimulator.
The inspired oxygen concentration was adjusted to maintain Pao2in the range 13.3-19.9 kPa (100-150 mm Hg) and total fresh gas flow adjusted to maintain Pacoz in the range 4.79-5.85 kPa (36-44 mm Hg).
Supplemental thiopentone was administered intravenously in 50 mg increments if anaesthesia was judged to be too light, as defined by sweating, tearing, or a systolic blood pressure more than 2.66 kPa (20 mm Hg) above the pre-induction pressure for five or more minutes.
At the close of the operation neuromuscular blockade was reversed with neostigmine and atropine in the pancuronium and curare cases. Following this the nitrous oxide was discontinued with the patient undisturbed and ventilation continued with oxygen alone for five minutes. At the end of this time heart rate, blood pressure and spontaneous tidal volume and minute volume were measured for each patient. During this period the gas flow was adjusted to maintain normocapnia and ventilation was by intermittent positive pressure whilst the patient was apnoeic.
The patients were then divided randomly into three Groups of thirty-three patients each; Group 1 patients were given naloxone 0.1 mg intravenously, Group It patients were given naloxone 0.2 mg and Group III patients were given 0.4 rag. Ventilation was continued by intermittent positive pressure while the patient was apnoeic and was changed to the spontaneous mode once the patient's own ventilatory activity returned. After two to three minutes, heart rate, blood pressure, tidal volume and minute volume were again measured. The patients were then transferred to the recovery room when ventilation was adequate. Adequate post-anaesthetic ventilalion was defined as a tidal volume of 5 ml. kg -t or more and a minute volume of 50 ml. kg -1 or more.
Statistical analysis was provided by the Computing Sciences Division of the University of Alberta using the Statistical Package for the Social Sciences programme. P was determined by one-way analysis of variance or Student's t-test for paired samples and was considered significant at 0.05 or less.
RESULTS
The Distribution of operative procedures is shown on Table I .
The control data for each of the three groups are shown on Table I1 and there is no significant 
Circulation
Blood pressure. Blood pressure was recorded both as systolic and mean arterial pressures. There were no significant differences among the groups with respect to pre-induction, prenaloxone and post-naloxone blood pressures. Comparing pre-naloxone with pre-induction systolic blood pressures there was a slight drop, ranging from 1 to 6 per cent, and a 0 to 5 per cent drop in mean arterial blood pressure. Comparing post-naloxone to pre-naloxone systolic blood pressures there were significant increases in all groups: four per cent in Group I, eight per cent in Group II, and seven per cent in Group III; mean arterial pressures increased by three, eight, and eight per cent in Groups I, 1I and I11 respectively and the increases were significant in Groups II and 1II (Table 111) .
Heart rate. There was no significant difference in heart rate among the groups before or after the naloxone administration; however, there was an increase in each group after naloxone administration, which was significant in Groups II and 111 the increases being 4, 11 and 8 per cent for Groups I, II and III respectively (Table III) .
Rate-pressure product. The rate-pressure product was determined by multiplying the heart rate by the systolic blood pressure; this increased by 7, 18 and 15 per cent in Groups I, II and III respectively after the administration of naloxone and the increases were significant in Groups I1 and III (Table III) .
Respiration
Tidal i,olume. There was no significant difference among the groups before naloxone and 56, 48 and 44 per cent of patients in Groups I, I1 and III respectively had tidal volumes of zero to 5 ml. kg -I. After the administration of naloxone there was a significant difference between Group [ and Groups II and 1II. In all groups mean tidal vohime virtually doubled and all patients, except one in Group I, had a tidal volume greater than 5.0 ml.kg -~. The increases were significant in Groups I and III (Table IV) . Three patients in Group I needed a supplemental dose of naloxone 0.1 mg intravenously to produce clinically adequate ventilation (fentanyl doses 3.0, 6.0 and 7.2 lag.kg-'). These patients 2. Significant post-pre-naloxone increase (0.02 > p > 0.01). Minute volume. There was no significant difference among the groups pre-naloxone, but post-naloxone Group I was significantly different from Groups II and III. Comparison within the groups showed that mean minute volume more than doubled after the administration of naloxone, the increases being significant in Groups I and 1II.
Before the administration of naloxone, minute volume was zero to 50 ml-kg -~ in 44 per cent of Group I, 39 per cent of Group I1 and 34 per cent of Group III patients. After the administration of naloxone no patient had a minute volume of less than 50 ml-kg -t (Table IV) .
Respiratory rate. There was no significant difference in respiratory rate among the groups, either before or after naloxone. In each group there was a trend toward an increase in rate after the administration of naloxone which was not significant; approximately 75 per cent of patients in each group had an increased rate, while the rate was reduced in the remaining 25 per cent. In Group I, 41 per cent had a rate of zero-10-rain -~ pre-naloxone and 3 per cent had a rate of less than 10. min ' post-naloxone; the figures for Group II are 39 and 0 per cent respectively, and for Group III, 28 and 3 per cent respectively (Table IV) .
Addendum. Two patients in the series received volatile agents for a short period after induction. One patient was given enflurane for the management of hypertension, the pre-induction pressure of 19.95/11.97 kPa (150/90 mm Hg) being at the high end of the blood pressure range; and one patient received halothane for post-induction bronchospasm.
DISCUSSION
Adequacy of anaesthesia. The protocol of the study included light premedication with oral diazepam reinforced by the preoperative visit and discussion with the patient by the author, and the only narcotic analgesic administered during the anaesthesia was fentanyl. Overall 79 per cent of the patients in this study received supplemental thiopentone and, in the majority of cases, it was required to attenuate the hypertensive response to surgical stimulation which occurred during the early stages of the operation when surgical stimulation may be at its highest and total dose of fentanyl low. This study shows that, with the fentanyl dosage used, anaesthesia was inadequate during the early stages of the operation and this may be obviated by increasing the fentanyl dosage or using low concentrations of volatile anaesthetic agents or supplemental thiopentone.
Effect of naloxone on the circulation. When the cardiovascular changes are considered together it is seen that under Ihe conditions of this study the increases in blood pressure, heart rate and ratepressure product were maximal in Group II (that is, after naloxone 0.2 rag) and they did not increase further or even decreased when the naloxone dose was increased to 0.4 mg.
The rate-pressure product is a useful index of left ventricular oxygen consumption. Evans and Matsuoka 6 and Starling and Visscher 7 showed that oxygen uptake in the heart-lung preparation is influenced by changes in intraventricular pressure and heart rate. Later, both Laurent, et al. a and Welch, et al. 9 demonstrated a linear correlation between minute oxygen consumption and mean systolic arterial pressure x heart rate in the isolated heart and this finding was confirmed in the intact dog by Neil, et al. io Thus the increases in rate-pressure product caused by naloxone and noted in this present study may be taken to reflect increases in myocardial oxygen consumption.
The observed cardiovascular changes induced by naloxone may be harmful to patients who have a diminished cardiac reserve and Flacke, et al. '~ report an instance where a patient developed acute pulmonary oedema after reversal of morphine anaesthesia with naloxone 0.4 rag; the patient was elderly and had undergone mitral valve replacement and coronary artery by-pass graft. No overt cardiovascular morbidity was noted in our study although the mean ratepressure product increased by up to 18 per cent and in one patient in Group II it increased by 140 per cent.
The results obtained in this study are similar to, though of a much lesser order than, those reported by Desmonts, et al. n2 who used phenoperidine as the narcotic analgesic and naloxone 1.5 + 0.25/.tg. kg -j. They found that the heart rate increased by 31 per cent, mean arterial blood pressure by 21 per cent and the ratepressure product by 77 per cent. In terms of hourly dosage the patients in this study and in that of Desmonts received similar doses of fentanyl on a potency basis; however, the total phenoperidine dose is not given.* The method of measuring the circulatory changes between the studies was different; in our study "spot" blood pressure readings were taken with a sphygmomanometer and cuff and "spot" heart rates were taken from the electrocardiogram on the oscilloscope; Desmonts, et al. used invasive blood pressure monitoring and recorded both the blood pressure trace and electrocardiogram on a four-channel recorder: these differences in monitoring and recording are unlikely to account for the differences observed between the two studies. The great majority of patients in this study received a neostigmine-atropine mixture to reverse residual neuromuscular blockade, whilst Desmonts' patients were given no neostigmine. The muscarinic effects of neostigmine may well have reduced the pulse rate change which we observed and thus explain the lesser changes in blood pressure and rate-pressure product. The time of taking the post-naloxone readings is important and may very well have influenced our findings: Desmonts, et al. gave the naloxone, extubated the trachea and took the readings five minutes later, and thus the tachycardia and hypertension of the extubation stimulus could have affected their results; on the other hand the circulatory and ventilatory parameters in our study were measured two to three minutes after the injection of naloxone, with the patients still intubated, and thus the maximal effects may not have been observed.
Effects of naloxone on ventilation. Forty-nine per cent of the patients in the study had a tidal volume from zero to 5 ml. kg -~ before the administration of naloxone and in each of the three groups mean tidal volume practically doubled after the administration of naloxone, suggesting that under the conditions of the study an optimal response was achieved in the majority of cases with naluxone 0.1 mg.
When ventilation was assessed on a minute volume basis 39 per cent of all patients had a minute volume of zero-5 ml. kg -~ , but after naloxone no group had a minute volume of less than 5 ml. kg -t. Overall, mean minute ventilation more *Phenoperidine, like fentanyl, is a short-acting narcotic. It has a chemical structure similar to that of meperidine. Equipotent analgesic doses are approximately fentanyl 0.1 mg (tO0 lag): phenoperidine 1. Iz than doubled after the administration of naloxone, the increase being maximal in Group II and falling offto an insignificant degree in Group III.
Examining respiratory rate, 36 per cent of the patients in the study had a rate of zero-10-min-I and after naloxone one patient each in Groups I and Ill had a rate of less than 10. min -~. Although mean respiratory rate increased after the administration of naloxone, in no group was this significant and in each group between 21 and 25 per cent of patients had a slowing of respiratory rate. This suggests that observing changes of respiratory rate alone after naloxone does not permit one to draw conclusions as to reversal of respiratory insufficiency.
In a study of neurosurgical patients Arner, et al. 2 showed that a single intravenous dose of naloxone I lag-kg ~ is effective in the rapid and definite reversal of the respiratory depression caused by fentauyl or phenoperidine and this dose correlated neither to the total amount of analgesics given, nor to the time period which had elapsed between the last dose of the analgesic drug and the administration of naloxone. This is essentially in agreement with our findings that naloxone 0.1 rag/65 kg (I.5 lag.kg -t) provides adequate reversal of fentanyl-induced respiratory depression in most instances. Anderson, et al) showed that naloxone 2.0 lag' kg -t sufficed to reverse the respiratory depressant effects of fentanyl; this dosage is between that used in Group 1 (0. I rag/65 kg = 1.5 lag. kg -1) and Group 1I (0.2 rag/65 kg = 3.1 lag. kg-~).
A further paper which is in preparation will present the early postoperative course of these same patients.
CONCLUSION
This study has shown that in low-dose fentanyl anaesthesia (1.5 ~tg. kg -~. min -~) nearly half (49 per cent) of the patients will have inadequate ventilation at the end of anaesthesia and that this can be reversed in the majority of cases by the administration of naloxone 0.l mg to provide adequate ventilation on the basis of spirometric measurements; occasionally naloxone 0.2 mg may be required. Notwithstanding this, the patients should be closely observed in the recovery room, as one patient in the study required further naloxone and physostigmine to provide clinically adequate ventilation and wakefulness. Increases in blood pressure, pulse rate and rate-pressure product after the administration of naloxone are significant and double on increasing the dose of naloxone from 0. I to 0.2 mg, but there is no further increase with 0.4 mg naloxone. Thus, from the cardiovascular aspect, naloxone 0.1 mg is a more favourable dose than 0.2 mg and, therefore, it is recommended that naloxone 0.1 mg be used to reverse the respiratory depressant effects of fentanyl and that the dose only be increased when this is insufficient to provide adequate ventilation.
